H-1B sponsorship profile: Tris Pharma, Inc. Across U.S. Department of Labor LCA disclosures, Tris Pharma, Inc filed 63 Labor Condition Applications covering 63 H-1B worker positions between fiscal year 2023 and fiscal year 2025. The employer’s DOL certification rate sits at 96.8% (61 certified of 63 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Tris Pharma, Inc’s H-1B petitions range from $60,902 at the low end to $237,453 at the high end, with a petition-weighted average of $90,768. That range reflects the mix of occupations the company sponsors, led by Method Validation Scientist II (9 petitions at $88,508 avg), followed by Method Validation Scientist III and Method Validation Scientist I. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Tris Pharma, Inc is headquartered in Monmouth Junction, NJ under NAICS code 325412, and places H-1B workers across 1 state, most heavily in NJ. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.